Editorial: Blood glucose control in 2010: 110 to 150 mg/dL and minimal variability

Critical Care Medicine

Volumn 38, Issue 3, 2010, Pages 993-995

  Vincent, Jean Louis ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

Glucose; Insulin; Mortality

Indexed keywords

CORTICOSTEROID; GLUCOSE;

CRITICALLY ILL PATIENT; EDITORIAL; GLUCOSE BLOOD LEVEL; HOSPITAL INFECTION; HUMAN; HYPERGLYCEMIA; INSULIN RESISTANCE; LENGTH OF STAY; MORBIDITY; MORTALITY; NUTRITION; OXIDATIVE STRESS; PRIORITY JOURNAL; STRESS; BLOOD; INTENSIVE CARE; NOTE; PROGNOSIS; RISK FACTOR;

BLOOD GLUCOSE; CRITICAL CARE; HOSPITAL MORTALITY; HUMANS; HYPERGLYCEMIA; PROGNOSIS; RISK FACTORS;

EID: 77249137199     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3181d16b2e     Document Type: Editorial

References (23)

1. Montori VM, Bistrian BR, McMahon MM: Hy-perglycemia in acutely ill patients. JAMA 2002; 288:2167-2169
2. Dungan KM, Braithwaite SS, Preiser JC: Stress hyperglycaemia. Lancet 2009; 373: 1798-1807
3. Capes SE, Hunt D, Malmberg K, et al: Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: A systematic overview. Lancet 2000; 355:773-778
4. Capes SE, Hunt D, Malmberg K, et al: Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: A systematic overview. Stroke 2001; 32:2426-2432
5. Van den Berghe G, Wouters P, Weekers F, et al: Intensive insulin therapy in the critically ill patients. N Engl J Med 2001; 345: 1359-1367
6. Vanhorebeek I, Langouche L, Van den Berghe G: Glycemic and nonglycemic effects of insulin: How do they contribute to a better outcome of critical illness? Curr Opin Crit Care 2005; 11:304-311
7. Brunkhorst FM, Engel C, Bloos F, et al: Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008; 358:125-139
8. Preiser JC, Devos P, Ruiz-Santana S, et al: A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: The Glucontrol study. Intensive Care Med 2009; 35:1738-1748
9. Finfer S, Chittock DR, Su SY, et al: Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009; 360:1283-1297
10. Van den Berghe G, Schetz M, Vlasselaers D, et al: Clinical review: Intensive insulin therapy in critically ill patients: NICE-SUGAR or Leuven blood glucose target? J Clin Endocri-nol Metab 2009; 94:3163-3170
11. Bagshaw SM, Bellomo R, Jacka MJ, et al: The impact of early hypoglycemia and blood glucose variability on outcome in critical illness. Crit Care 2009; 13:R91
12. Hermanides J, Vriesendorp TM, Bosman RJ, et al: Glucose variability is associated with intensive care unit mortality. Crit Care Med 2010; 38:838-842
13. Ali NA, O'Brien JM, Jr., Dungan K, et al: Glucose variability and mortality in patients with sepsis. Crit Care Med 2008; 36:2316-2321
14. Egi M, Bellomo R, Stachowski E, et al: Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology 2006; 105:244-252
15. Hirshberg E, Larsen G, Van Duker H: Alterations in glucose homeostasis in the pediat-ric intensive care unit: Hyperglycemia and glucose variability are associated with increased mortality and morbidity. Pediatr Crit Care Med 2008; 9:361-366
16. Dossett LA, Cao H, Mowery NT, et al: Blood glucose variability is associated with mortality in the surgical intensive care unit. Am Surg 2008; 74:679-685
17. Waeschle RM, Moerer O, Hilgers R, et al: The impact of the severity of sepsis on the risk of hypoglycaemia and glycaemic variability. Crit Care 2008; 12:R129
18. Quagliaro L, Piconi L, Assaloni R, et al: Intermittent high glucose enhances apo-ptosis related to oxidative stress in human umbilical vein endothelial cells: The role of protein kinase C and NAD(P)H-oxidase activation. Diabetes 2003; 52:2795-2804
19. Monnier L, Mas E, Ginet C, et al: Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hy-perglycemia in patients with type 2 diabetes. JAMA 2006; 295:1681-1687
20. Watada H, Azuma K, Kawamori R: Glucose fluctuation on the progression of diabetic mac-roangiopathy: New findings from monocyte adhesion to endothelial cells. Diabetes Res Clin Pract 2007; 77(Suppl 1):S58-S61
21. Risso A, Mercuri F, Quagliaro L, et al: Intermittent high glucose enhances apoptosis in human umbilical vein endothelial cells in culture. Am J Physiol Endocrinol Metab 2001; 281:E924-E930
22. Ali NA, Krinsley JS, Preiser JC: Glucose variability in critically ill patients. In: Yearbook of Intensive Care and Emergency Medicine. Vincent JL (Ed). Heidelberg, Springer, 2009, pp 728-737
23. Dellinger RP, Levy MM, Carlet JM, et al: Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008; 36: 296-327